- Home
- WAVE vs AKTX Comparison
WAVE vs AKTX Comparison
Compare WAVE & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAVE
- AKTX
- Stock Information
- Founded
- WAVE 2011
- AKTX N/A
- Country
- WAVE Israel
- AKTX United States
- Employees
- WAVE N/A
- AKTX N/A
- Industry
- WAVE Electric Utilities: Central
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- WAVE Utilities
- AKTX Health Care
- Exchange
- WAVE Nasdaq
- AKTX Nasdaq
- Market Cap
- WAVE 35.0M
- AKTX 29.1M
- IPO Year
- WAVE 2021
- AKTX N/A
- Fundamental
- Price
- WAVE $6.04
- AKTX $1.45
- Analyst Decision
- WAVE Strong Buy
- AKTX
- Analyst Count
- WAVE 1
- AKTX 0
- Target Price
- WAVE $15.00
- AKTX N/A
- AVG Volume (30 Days)
- WAVE 29.1K
- AKTX 28.2K
- Earning Date
- WAVE 05-05-2025
- AKTX 04-16-2025
- Dividend Yield
- WAVE N/A
- AKTX N/A
- EPS Growth
- WAVE N/A
- AKTX N/A
- EPS
- WAVE N/A
- AKTX N/A
- Revenue
- WAVE $168,000.00
- AKTX N/A
- Revenue This Year
- WAVE $325.00
- AKTX N/A
- Revenue Next Year
- WAVE $85.71
- AKTX N/A
- P/E Ratio
- WAVE N/A
- AKTX N/A
- Revenue Growth
- WAVE N/A
- AKTX N/A
- 52 Week Low
- WAVE $2.20
- AKTX $0.85
- 52 Week High
- WAVE $17.63
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- WAVE 45.06
- AKTX 64.05
- Support Level
- WAVE $5.64
- AKTX $1.03
- Resistance Level
- WAVE $6.45
- AKTX $1.58
- Average True Range (ATR)
- WAVE 0.71
- AKTX 0.16
- MACD
- WAVE 0.08
- AKTX 0.02
- Stochastic Oscillator
- WAVE 59.07
- AKTX 77.72
About WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).